Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine. Taverna JA, Hung CN, Williams M, Williams R, et al. Lung Cancer 2024;190:107533.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Taverna JA, Hung CN, Williams M, Williams R, et al. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine. Lung Cancer 2024;190:107533.
PMID: 38520909